Tamsulosin
Tamsulosin is a pharmaceutical drug with 107 clinical trials. Currently 15 active trials ongoing. Historical success rate of 88.2%.
Success Metrics
Based on 60 completed trials
Phase Distribution
Phase Distribution
14
Early Stage
12
Mid Stage
57
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
84.5%
60 of 71 finished
15.5%
11 ended early
15
trials recruiting
107
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Comparison of Alpha Blockers (Terazosin and Tamsulosin) in Reducing Ureteral Stent Related Symptoms
Effect of Different Dosing Regimens of Tadalafil or Tamsulosin Combined With 5α-Reductase Inhibitors on Urinary and Sexual Outcomes in Benign Prostatic Hyperplasia
Tamsulosin With or Without Tadalafil for Trial Without Catheter After Acute Urinary Retention Due to Benign Prostatic Hyperplasia
Comparison of Mirabegron and Tamsulosin for Ureteral Stone Expulsion
Tamsulosin and Intraureteral Aminophylline for Ureteral Access During RIRS
Clinical Trials (107)
Comparison of Alpha Blockers (Terazosin and Tamsulosin) in Reducing Ureteral Stent Related Symptoms
Effect of Different Dosing Regimens of Tadalafil or Tamsulosin Combined With 5α-Reductase Inhibitors on Urinary and Sexual Outcomes in Benign Prostatic Hyperplasia
Tamsulosin With or Without Tadalafil for Trial Without Catheter After Acute Urinary Retention Due to Benign Prostatic Hyperplasia
Comparison of Mirabegron and Tamsulosin for Ureteral Stone Expulsion
Tamsulosin and Intraureteral Aminophylline for Ureteral Access During RIRS
L-Citrulline Versus Tamsulosin for Medical Expulsive Therapy of Distal Ureteral Stones
Safety and Efficacy of Combination of Tamsulosin 0.4 mg Plus Tadalafil 5mg Versus 2.5 mg
Function of Tamsulosin in Older Males Undergoing Surgery With Indwelling Catheter
Impact of Tamsulosin on Post-Operative Urinary Retention Following Pelvic Reconstructive Surgery
Silodosin vs Tamsulosin for LUTS Due to BPH: A Randomized Crossover Trial
Post Operative Urinary Retention (POUR) Following Thoracic Oncological Surgery
Tamsulosin and the Risk of Serious Adverse Events
Prospective Trial Comparing Oxybutynin and Tamsulosin for Stent Pain in the Pediatric Population
Efficacy and Safety of Longidaze in the Treatment of Lower Urinary Tract Symptoms Associated With Benign Prostatic Hyperplasia
Evaluation of Mirabegron Versus Tamsulosin or Their Combination in Treatment of Lower Urinary Tract Symptoms
Effect of Preoperative Tamsulosin on Postoperative Urinary Retention
Comparative Study Between Rezum and Tamsulosin
Prevention of Postoperative Urinary Retention With Treatment of Tamsulosin 5 Days Prior to Lower Limb Arthroplasty
Deprescribing Tamsulosin in Older Men
Comparing Tamsulosin and Solifenacin for Relieving Double J Stent Symptoms: Using the USSQ.
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 107